Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alignment Healthcare, Inc. Director's Dealing 2021

Nov 3, 2021

31270_dirs_2021-11-03_f3fa2680-4a67-4dbf-ba0a-61d0368297b2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alignment Healthcare, Inc. (ALHC)
CIK: 0001832466
Period of Report: 2021-11-01

Reporting Person: KAO JOHN E (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-01 Common Stock S 70698 $19.9111 Disposed 4014339 Indirect
2021-11-02 Common Stock S 29302 $19.9284 Disposed 3985037 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 311030 Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The reported prices in column 4 are weighted-average prices. The Reporting Person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (4) to this Form 4.

F2: The shares were sold in multiple transactions at prices ranging from $19.37 to $20.18 per share.

F3: Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

F4: The shares were sold in multiple transactions at prices ranging from $19.58 to $20.45 per share.

F5: Represents 311,030 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of Alignment Healthcare, Inc., that will vest 25% on the first four anniversaries of the initial vesting date.